The company has no revenue stream and is burning ~$11.5M/quarter in operating expenses. With only $15M cash and a $22M market cap, dilution risk is extreme. Monitor for the Series B warrant trigger (5th CLL patient dosing) as a potential near-term catalyst, but the fundamental trajectory is deteriorating.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · May 13 $10.00entry
- T+1 · 6mo ago +2.00%α +1.21% · $10.20
- T+5 · 6mo ago 0.00%α +0.14% · $10.00
- T+20 · 5mo ago −14.00%α −13.39% · $8.60
- T+60 · due 3mo ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Curis reported Q1 2026 results with zero revenue (post-Erivedge sale) and a net loss of $24.2M, significantly worse than the prior year's $10.6M loss. The company's cash runway extends into H2 2027 only if Series B warrants are exercised, and the stock has a $22M market cap with a history of poor post-earnings performance.
Key Financial Metrics
Key Facts
- Zero revenue in Q1 2026 vs $2.4M in Q1 2025 due to sale of Erivedge royalties
- Net loss of $24.2M ($1.25/share) vs $10.6M ($1.25/share) in Q1 2025
- Cash and cash equivalents of $15.0M as of March 31, 2026
- Operating cash burn of $11.5M in Q1 2026 vs $10.2M in Q1 2025
- Warrant liability of $1.9M from January 2026 PIPE financing
- Shares outstanding increased to ~40M from ~12.9M at year-end 2025
- Cash runway guidance extends into H2 2027 only with Series B warrant exercise
- Prior earnings report (Q4 2025) showed net income of $19.4M from a one-time gain on asset sale
Financial Impact
Revenue collapsed to zero; net loss more than doubled to $24.2M; cash burn rate increased
Risk Factors
- Zero revenue going forward after Erivedge royalty sale
- Cash runway only extends to H2 2027 with warrant exercise; without it, runway is much shorter
- Massive dilution: shares outstanding tripled to ~40M from ~12.9M
- No approved products; clinical-stage pipeline with binary outcomes
- Nasdaq listing compliance risk given low market cap and cash position
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001108205-26-000059 |
| Document: cris-20260512.htm | 0001108205-26-000059 |
| Document: 0001108205-26-000059-index-headers.html | 0001108205-26-000059 |
| Document: 0001108205-26-000059-index.html | 0001108205-26-000059 |
| Document: 0001108205-26-000059.txt | 0001108205-26-000059 |
| 8-K Data (Synthetic) | 0001108205-26-000059 |
Track record
18 reports on CRIS
7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers